GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review
Nasreen Alfaris(King Fahd Medical City), Fatima Cody Stanford(Massachusetts General Hospital)
Cited by 157
Related Papers
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.3k
Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society
|American Journal of Clinical Nutrition|2025|76
The Role of the Pediatrician in the Promotion of Healthy, Active Living
|PEDIATRICS|2024|33
Gender Representation Among United States Medical Board Leadership
|Journal of Women s Health|2022|21